Cibus and Biographica Announce Collaboration Using Artificial Intelligence (AI) to Advance Disease Resistance in Canola and Oilseed Rape
Cibus (Nasdaq: CBUS) and Biographica have announced a collaborative pilot project to advance disease resistance in oilseed rape and Canola. The partnership combines Biographica's proprietary AI and machine learning platform for gene target identification with Cibus' expertise in crop trait development. Biographica will analyze gene targets associated with disease resistance, while Cibus will focus on developing crop varieties with enhanced resilience. The collaboration aims to identify multiple modes of action for developing durable disease resistance in plants, potentially accelerating the delivery of improved crop varieties to farmers worldwide.
Cibus (Nasdaq: CBUS) e Biographica hanno annunciato un progetto pilota collaborativo per promuovere la resistenza alle malattie nel colza e nella colza canola. La partnership combina la piattaforma proprietaria di IA e apprendimento automatico di Biographica per l'identificazione dei target genetici con l'expertise di Cibus nello sviluppo delle caratteristiche delle colture. Biographica analizzerà i target genetici associati alla resistenza alle malattie, mentre Cibus si concentrerà sullo sviluppo di varietà di colture con resistenza migliorata. La collaborazione mira a identificare molteplici modalità d'azione per sviluppare una resistenza duratura alle malattie nelle piante, con l'obiettivo di accelerare la disponibilità di varietà di colture migliorate per gli agricoltori di tutto il mondo.
Cibus (Nasdaq: CBUS) y Biographica han anunciado un proyecto piloto colaborativo para avanzar en la resistencia a enfermedades en la colza y canola. La asociación combina la plataforma de IA y aprendizaje automático patentada de Biographica para la identificación de objetivos genéticos con la experiencia de Cibus en el desarrollo de características de cultivos. Biographica analizará los objetivos genéticos asociados con la resistencia a enfermedades, mientras que Cibus se centrará en desarrollar variedades de cultivos con una mayor resiliencia. La colaboración tiene como objetivo identificar múltiples modos de acción para desarrollar una resistencia duradera a las enfermedades en las plantas, lo que podría acelerar la entrega de variedades de cultivos mejoradas a los agricultores de todo el mundo.
Cibus (Nasdaq: CBUS)와 Biographica는 유채 및 카놀라의 질병 저항성을 향상시키기 위한 협력 파일럿 프로젝트를 발표했습니다. 이 파트너십은 Biographica의 유전자 표적 식별을 위한 독점 AI 및 머신러닝 플랫폼과 Cibus의 작물 형질 개발 전문성을 결합합니다. Biographica는 질병 저항성과 관련된 유전자 표적을 분석하고, Cibus는 개선된 내성을 지닌 작물 품종 개발에 집중합니다. 이 협력은 식물에서 지속적인 질병 저항성을 개발하기 위해 여러 작용 방식을 식별하는 것을 목표로 하며, 이는 전 세계 농부들에게 개선된 작물 품종을 제공하는 속도를 높일 수 있습니다.
Cibus (Nasdaq: CBUS) et Biographica ont annoncé un projet pilote collaboratif pour faire progresser la résistance aux maladies dans le colza et la canola. Ce partenariat combine la plateforme IA et apprentissage automatique propriétaire de Biographica pour l'identification des cibles génétiques avec l'expertise de Cibus dans le développement des caractéristiques des cultures. Biographica analysera les cibles génétiques associées à la résistance aux maladies, tandis que Cibus se concentrera sur le développement de variétés de cultures avec une résilience accrue. Cette collaboration vise à identifier plusieurs modes d'action pour développer une résistance durable aux maladies chez les plantes, ce qui pourrait potentiellement accélérer la livraison de variétés de cultures améliorées aux agriculteurs du monde entier.
Cibus (Nasdaq: CBUS) und Biographica haben ein gemeinsames Pilotprojekt zur Förderung der Krankheitsresistenz in Raps und Canola angekündigt. Die Partnerschaft kombiniert Biographicas proprietäre KI- und Maschinenlernplattform zur Identifizierung von Gen-Zielen mit Cibus' Expertise in der Entwicklung von Pflanzeigenschaften. Biographica wird Gen-Ziele analysieren, die mit der Krankheitsresistenz verbunden sind, während sich Cibus auf die Entwicklung von Pflanzenvarianten mit verbesserter Resilienz konzentriert. Das Ziel der Zusammenarbeit ist es, mehrere Wirkungsweisen zur Entwicklung einer dauerhaften Krankheitsresistenz in Pflanzen zu identifizieren, was potenziell die Lieferung verbesserter Pflanzenvarianten an Landwirte weltweit beschleunigen könnte.
- Strategic partnership combining AI technology with crop development expertise
- Potential for new revenue streams through improved disease-resistant crop varieties
- Expansion of gene target inventory for trait development
- Project is in pilot phase with no immediate revenue impact
- Success in identifying viable gene targets not guaranteed
Insights
This collaboration represents a strategic move into AI-driven trait discovery, potentially accelerating Cibus' development pipeline for disease-resistant crops. The partnership with Biographica adds valuable AI capabilities to identify gene editing targets, particularly important for complex traits like disease resistance that often require multiple genetic modifications. The focus on canola and oilseed rape targets a significant market, as these crops face substantial disease pressure affecting global yields.
The emphasis on developing multiple modes of action for disease resistance suggests a comprehensive approach to creating durable traits. However, this is an early-stage pilot project with no immediate revenue impact. Success will depend on converting identified targets into commercially viable traits that can generate licensing revenues. The timeline from discovery to commercialization typically spans several years in agricultural biotechnology.
Cibus and Biographica to collaborate on identifying gene editing targets for Cibus’ disease resistance trait development
Biographica’s proprietary AI platform linked with Cibus’ crop editing abilities provide opportunities for discovery and commercial application
SAN DIEGO and LONDON, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies for royalties, and Biographica, a UK-based leader in AI and graph machine learning for gene discovery, are pleased to announce a collaborative pilot project focused on advancing disease resistance in oilseed rape and Canola.
This partnership leverages Biographica’s proprietary platform to identify and prioritize targets for gene editing, aiming to develop resistance against critical diseases impacting crop health, yield and quality.
Under this agreement, Biographica will utilize its cutting-edge AI and machine learning technology to analyze gene targets associated with disease resistance in oilseed rape and Canola and set the stage for future crop improvement strategies.
“This collaboration marks a significant milestone in unlocking the potential of advanced machine learning for agricultural innovation,” said Cecy Price, CEO at Biographica. “Combining Biographica’s unique machine learning trait discovery platform with Cibus’ expertise in crop trait development allows us to unlock new insights into disease resistance, paving the way for more resilient crops and sustainable agricultural practices.”
Tony Moran, Senior Vice President for International Development at Cibus, added, “We are excited to work alongside Biographica to identify impactful gene targets, enabling the development of crop varieties that can withstand disease pressure in the field with benefits for farmers, the environment, and food security.”
Dr. Greg Gocal, Executive Vice President and Chief Scientific Officer, added, “We have made plant disease resistance an important pillar of our work. This is a critically important need in farming. Developing durable disease resistance in plants will require identifying multiple modes of action. This partnership with Biographica is an important extension of our work in building our inventory of gene targets associated with developing different modes of action for this important trait.”
The collaboration reflects a commitment by both companies to push the boundaries of crop science and contribute to sustainable agriculture. This pilot project has the potential to accelerate the delivery of improved crop varieties with advanced disease resistant traits to farmers worldwide.
About Biographica
Biographica, Ltd. is a UK-based company specializing in advanced machine learning algorithms for target discovery. Their proprietary Biographica Platform enables researchers to identify and prioritize gene targets effectively, supporting breakthroughs in gene editing and other advanced biological applications.
About Cibus
Cibus is a leading independent plant trait company that develops and licenses plant traits to seed companies for royalties. Cibus is not a seed company, but rather a technology company that uses its proprietary gene editing technology to develop and commercialize plant traits at a fraction of the time and cost of conventional breeding. Cibus’ strategy is focused on commercializing productivity traits for the world’s major row crops with large acreage such as: canola, rice, and soybean. The Company targets traits that help manage farmers’ seed productivity, economics and sustainability challenges such as weeds, disease, and insects. The United Nations estimates that the impacts from these challenges cost the global economy approximately
CIBUS CONTACTS:
INVESTOR RELATIONS
Karen Troeber
ktroeber@cibus.com
858-450-2636
Jeff Sonnek – ICR
jeff.sonnek@icrinc.com
MEDIA RELATIONS
media@cibus.com
Colin Sanford
colin@bioscribe.com
203-918-4347
FAQ
What is the purpose of Cibus (CBUS) collaboration with Biographica?
How will Biographica's AI technology benefit Cibus (CBUS)?
What is the expected outcome of the Cibus (CBUS) and Biographica pilot project?
